Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Hudspith

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|April 1, 1997
The therapeutic potential of neuropeptide Y in cardiovascular diseaseM J Hudspith, R Munglani
International Journal of Obstetric Anesthesia|July 1, 1996
The anaesthetic management of intracranial haemorrhage from arteriovenous malformations during pregnancy: three casesM J Hudspith, P A Popham
Expert Opinion on Investigational Drugs|June 1, 1997
The therapeutic potential of neuropeptide Y in central nervous system disorders with special reference to pain and sympathetically maintained painN Cougnon, M J Hudspith, R Munglani
Drugs|September 1, 1996
The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensiveR Munglani, M J Hudspith, S P Hunt
Brain Research|March 20, 1999
Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painM J Hudspith, S Harrisson, G Smith, et al.
Brain Research|March 20, 1999
Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painR Munglani, M J Hudspith, B Fleming, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|April 1, 1997
The therapeutic potential of neuropeptide Y in cardiovascular diseaseM J Hudspith, R Munglani
International Journal of Obstetric Anesthesia|July 1, 1996
The anaesthetic management of intracranial haemorrhage from arteriovenous malformations during pregnancy: three casesM J Hudspith, P A Popham
Expert Opinion on Investigational Drugs|June 1, 1997
The therapeutic potential of neuropeptide Y in central nervous system disorders with special reference to pain and sympathetically maintained painN Cougnon, M J Hudspith, R Munglani
Drugs|September 1, 1996
The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensiveR Munglani, M J Hudspith, S P Hunt
Brain Research|March 20, 1999
Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painM J Hudspith, S Harrisson, G Smith, et al.
Brain Research|March 20, 1999
Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painR Munglani, M J Hudspith, B Fleming, et al.
Pageof 1